evans blue has been researched along with physostigmine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Ally, A; Mitchell, JH; Nóbrega, AC; Wilson, LB | 1 |
Aubriot, S; Baubichon, D; Carpentier, P; Dorandeu, F; Foquin, A; Lallement, G | 1 |
3 other study(ies) available for evans blue and physostigmine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Cardiovascular effects elicited by central administration of physostigmine via M2 muscarinic receptors in conscious cats.
Topics: Animals; Atropine; Behavior, Animal; Blood Pressure; Cardiovascular Physiological Phenomena; Cardiovascular System; Cats; Consciousness; Dose-Response Relationship, Drug; Evans Blue; Heart Rate; Injections, Intraventricular; Pentobarbital; Physostigmine; Receptors, Muscarinic | 1995 |
Subchronic administration of various pretreatments of nerve agent poisoning. I. Protection of blood and central cholinesterases, innocuousness towards blood-brain barrier permeability.
Topics: Alkaloids; Animals; Blood-Brain Barrier; Brain; Cholinesterase Inhibitors; Cholinesterases; Erythrocytes; Evans Blue; Guinea Pigs; Male; Microscopy, Fluorescence; Neuroprotective Agents; Physostigmine; Pyridostigmine Bromide; Serum Albumin; Sesquiterpenes | 2001 |